{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:45:57Z","timestamp":1791859557654,"version":"4.3.4"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Aktuell befinden sich in der DACH-Region etwa 13\u202fMio. Frauen in der Peri- und Postmenopause. Diese Lebensphase f\u00fchrt zu relevanten somatischen, psychischen und metabolischen Ver\u00e4nderungen. Leider bleiben auch heutzutage noch viele Beschwerden unbehandelt, was zentrale Auswirkungen auf die Lebensqualit\u00e4t und die Berufst\u00e4tigkeit von Frauen hat. Moderne Konzepte der menopausalen Hormontherapie sowie nichthormonelle Therapieans\u00e4tze dienen dazu, die Gesundheit und Lebensqualit\u00e4t von betroffenen Frauen gezielt zu verbessern. Diese werden nach wie vor nur unzureichend eingesetzt. Das vorliegende DACH-Konsensuspapier beleuchtet die derzeit bekannte Evidenz, geht auf Risikofaktoren ein und gibt gezielte Empfehlungen f\u00fcr die t\u00e4gliche Praxis.<\/jats:p>","DOI":"10.1007\/s00508-026-02832-7","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:36:04Z","timestamp":1791826564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peri- und Postmenopause: aktuelle diagnostische und therapeutische Aspekte f\u00fcr die DACH-Region","Perimenopause and postmenopause: acute diagnostic and therapeutic aspects for the DACH region"],"prefix":"10.1007","author":[{"given":"Bettina","family":"Toth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris Maria","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Weidlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schaudig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2832_CR1","unstructured":"Germany \u2013 Population pyramid. Available from: https:\/\/countryeconomy.com\/demography\/population-structure\/germany. Accessed: 19. Aug. 2026."},{"key":"2832_CR2","unstructured":"Austria \u2013 Population pyramid. Available from: https:\/\/countryeconomy.com\/demography\/population-structure\/austria. Accessed: 19. Aug. 2026."},{"key":"2832_CR3","unstructured":"Switzerland \u2013 Population pyramid. Available from: https:\/\/countryeconomy.com\/demography\/population-structure\/switzerland. Accessed: 19. Aug. 2026."},{"key":"2832_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s41974-023-00252-3","volume":"33","author":"DM Gruber","year":"2023","unstructured":"Gruber\u00a0DM, Helwig\u00a0SK. Konsen in den Wechseljahren \u2013 ist das noch State of the Art? J. Gyn\u00e4kol. Endokrinol. 2023;33:45\u20139. https:\/\/doi.org\/10.1007\/s41974-023-00252-3.","journal-title":"J. Gyn\u00e4kol. Endokrinol"},{"key":"2832_CR5","unstructured":"Bundesministerium f\u00fcr Arbeit, Soziales, Gesundheit, Pflege und Konsumentenschutz. Frauengesundheitsbericht. 2022. https:\/\/www.sozialministerium.gv.at\/dam\/jcr:7157d267-ef16-4a8b-8861-56e9cbf54089\/Frauengesundheitsbericht_2022_FINAL.pdf. Zugegriffen: 19. Aug. 2026."},{"key":"2832_CR6","unstructured":"The Parliament. Why Europe needs to think differently about menopause. 2025. https:\/\/www.theparliamentmagazine.eu\/partner\/article\/positive-change-why-europe-needs-to-think-differently-about-menopause. Zugegriffen: 19. Aug. 2026."},{"key":"2832_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.maturitas.2020.09.010","volume":"143","author":"M Evandrou","year":"2021","unstructured":"Evandrou\u00a0M, Falkingham\u00a0J, Qin\u00a0M, Vlachantoni\u00a0A. Menopausal transition and change in employment: Evidence from the National Child Development Study. Maturitas. 2021;143:96\u2013104. https:\/\/doi.org\/10.1016\/j.maturitas.2020.09.010.","journal-title":"Maturitas"},{"key":"2832_CR8","unstructured":"Bundesministerium f\u00fcr Arbeit, Soziales, Gesundheit, Pflege und Konsumentenschutz. Menstruationsgesundheitsbericht 2024. Available from: https:\/\/broschuerenservice.sozialministerium.gv.at\/Home\/Download?publicationId=803&attachmentName=Menstruationsgesundheitsbericht_2024.pdf. Accessed: 19. Aug. 2026."},{"issue":"4 Pt 1","key":"2832_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/gme.0b013e318174ea4d","volume":"15","author":"HG Burger","year":"2008","unstructured":"Burger\u00a0HG, Hale\u00a0GE, Dennerstein\u00a0L, Robertson\u00a0DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause. 2008;15(4 Pt 1):603\u201312. https:\/\/doi.org\/10.1097\/gme.0b013e318174ea4d.","journal-title":"Menopause"},{"issue":"2","key":"2832_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2741\/s166","volume":"3","author":"JC Prior","year":"2011","unstructured":"Prior\u00a0JC, Hitchcock\u00a0CL. The endocrinology of perimenopause: need for a\u00a0paradigm shift. Front Biosci (Schol Ed). 2011;3(2):474\u201386. https:\/\/doi.org\/10.2741\/s166.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"2","key":"2832_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00404-022-06457-9","volume":"306","author":"P Stute","year":"2022","unstructured":"Stute\u00a0P, Eversheim\u00a0H, Ortius-Lechner\u00a0D, May\u00a0M, Feig\u00a0C. Care reality of menopausal women in Germany: healthcare research using quantitative (SHI claims data) and qualitative (survey) data collection. Arch Gynecol Obstet. 2022;306(2):513\u201321. https:\/\/doi.org\/10.1007\/s00404-022-06457-9.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2832_CR12","first-page":"16","volume":"116","author":"GA Hauser","year":"1994","unstructured":"Hauser\u00a0GA, Huber\u00a0IC, Keller\u00a0PJ, Lauritzen\u00a0C, Schneider\u00a0HP. Evaluation der klimakterischen Beschwerden (Menopause Rating Scale [MRS]) [Evaluation of climacteric symptoms (Menopause Rating Scale)]. Zentralbl Gynakol. 1994;116(1):16\u201323.","journal-title":"Zentralbl Gynakol"},{"issue":"1","key":"2832_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19280-5","volume":"24","author":"Y Fang","year":"2024","unstructured":"Fang\u00a0Y, Liu\u00a0F, Zhang\u00a0X, Chen\u00a0L, Liu\u00a0Y, Yang\u00a0L, et\u00a0al. Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis. BMC Public Health. 2024;24(1)1767. https:\/\/doi.org\/10.1186\/s12889-024-19280-5.","journal-title":"BMC Public Health"},{"key":"2832_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bpobgyn.2021.10.009","volume":"81","author":"E Hogervorst","year":"2022","unstructured":"Hogervorst\u00a0E, Craig\u00a0J, O\u2019Donnell\u00a0E. Cognition and mental health in menopause: A\u00a0review. Best Pract Res Clin Obstet Gynaecol. 2022;81:69\u201384. https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.10.009.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"2832_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/GME.0000000000000767","volume":"24","author":"BM Zeleke","year":"2017","unstructured":"Zeleke\u00a0BM, Bell\u00a0RJ, Billah\u00a0B, Davis\u00a0SR. Hypoactive sexual desire dysfunction in community-dwelling older women. Menopause. 2017;24(4):391\u20139. https:\/\/doi.org\/10.1097\/GME.0000000000000767.","journal-title":"Menopause"},{"issue":"8","key":"2832_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082092","volume":"11","author":"KI Voumvourakis","year":"2023","unstructured":"Voumvourakis\u00a0KI, Sideri\u00a0E, Papadimitropoulos\u00a0GN, Tsantzali\u00a0I, Hewlett\u00a0P, Kitsos\u00a0D, et\u00a0al. The Dynamic Relationship between the Glymphatic System, Aging, Memory, and Sleep. Biomedicines. 2023;11(8)2092. https:\/\/doi.org\/10.3390\/biomedicines11082092.","journal-title":"Biomedicines"},{"issue":"2","key":"2832_CR17","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1542\/peds.2004-2629","volume":"117","author":"EO Johnson","year":"2006","unstructured":"Johnson\u00a0EO, Roth\u00a0T, Schultz\u00a0L, Breslau\u00a0N. Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics. 2006;117(2):e247\u2013e56. https:\/\/doi.org\/10.1542\/peds.2004-2629.","journal-title":"Pediatrics"},{"issue":"20","key":"2832_CR18","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/archinte.165.20.2370","volume":"165","author":"HM Kravitz","year":"2005","unstructured":"Kravitz\u00a0HM, Janssen\u00a0I, Santoro\u00a0N, Bromberger\u00a0JT, Schocken\u00a0M, Everson-Rose\u00a0SA, et\u00a0al. Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med. 2005;165(20):2370\u20136. https:\/\/doi.org\/10.1001\/archinte.165.20.2370.","journal-title":"Arch Intern Med"},{"issue":"8","key":"2832_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/GME.0000000000001793","volume":"28","author":"RE Nappi","year":"2021","unstructured":"Nappi\u00a0RE, Kroll\u00a0R, Siddiqui\u00a0E, Stoykova\u00a0B, Rea\u00a0C, Gemmen\u00a0E, et\u00a0al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause. 2021;28(8):875\u201382. https:\/\/doi.org\/10.1097\/GME.0000000000001793. Erratum in: Menopause. 2022;29(6):759.","journal-title":"Menopause"},{"issue":"5","key":"2832_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia\u00a0MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387\u201394. https:\/\/doi.org\/10.1378\/chest.14-0970.","journal-title":"Chest"},{"key":"2832_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/NSS.S125807","volume":"10","author":"FC Baker","year":"2018","unstructured":"Baker\u00a0FC, de Zambotti\u00a0M, Colrain\u00a0IM, Bei\u00a0B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:73\u201395. https:\/\/doi.org\/10.2147\/NSS.S125807.","journal-title":"Nat Sci Sleep"},{"issue":"8","key":"2832_CR22","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"YS Ju","year":"2017","unstructured":"Ju\u00a0YS, Ooms\u00a0SJ, Sutphen\u00a0C, Macauley\u00a0SL, Zangrilli\u00a0MA, Jerome\u00a0G, et\u00a0al. Slow wave sleep disruption increases cerebrospinal fluid amyloid\u2011\u03b2 levels. Brain Commun. 2017;140(8):2104\u201311. https:\/\/doi.org\/10.1093\/brain\/awx148.","journal-title":"Brain"},{"key":"2832_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00705","volume":"14","author":"YF Lee","year":"2020","unstructured":"Lee\u00a0YF, Gerashchenko\u00a0D, Timofeev\u00a0I, Bacskai\u00a0BJ, Kastanenka\u00a0KV. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer\u2019s Disease. Front Neurosci. 2020;14:705. https:\/\/doi.org\/10.3389\/fnins.2020.00705.","journal-title":"Front Neurosci"},{"issue":"3","key":"2832_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1258\/mi.2008.008013","volume":"14","author":"N Kalleinen","year":"2008","unstructured":"Kalleinen\u00a0N, Polo-Kantola\u00a0P, Himanen\u00a0SL, Alhola\u00a0P, Joutsen\u00a0A, Urrila\u00a0AS, et\u00a0al. Sleep and the menopause - do postmenopausal women experience worse sleep than premenopausal women? Menopause Int. 2008;14(3):97\u2013104. https:\/\/doi.org\/10.1258\/mi.2008.008013.","journal-title":"Menopause Int"},{"key":"2832_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101710","volume":"66","author":"A Haufe","year":"2022","unstructured":"Haufe\u00a0A, Baker\u00a0FC, Leeners\u00a0B. The role of ovarian hormones in the pathophysiology of perimenopausal sleep disturbances: A\u00a0systematic review. Sleep Med Rev. 2022;66:101710. https:\/\/doi.org\/10.1016\/j.smrv.2022.101710.","journal-title":"Sleep Med Rev"},{"key":"2832_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.genhosppsych.2026.03.010","volume":"100","author":"I Balasubramanian","year":"2026","unstructured":"Balasubramanian\u00a0I, Abhijita\u00a0B, Krishnamoorthy\u00a0Y, Gnanadhas\u00a0J, Beg\u00a0MJ, Menon\u00a0V. Prevalence and incidence of depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women: Systematic review and meta-analysis. Gen Hosp Psychiatry. 2026;100:325\u201335. https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.03.010.","journal-title":"Gen Hosp Psychiatry"},{"key":"2832_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jad.2024.04.041","volume":"357","author":"Y Badawy","year":"2024","unstructured":"Badawy\u00a0Y, Spector\u00a0A, Li\u00a0Z, Desai\u00a0R. The risk of depression in the menopausal stages: A\u00a0systematic review and meta-analysis. J\u00a0Affect Disord. 2024;357:126\u201333. https:\/\/doi.org\/10.1016\/j.jad.2024.04.041.","journal-title":"J Affect Disord"},{"issue":"10430","key":"2832_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0140-6736(23)02801-5","volume":"403","author":"L Brown","year":"2024","unstructured":"Brown\u00a0L, Hunter\u00a0MS, Chen\u00a0R, Crandall\u00a0CJ, Gordon\u00a0JL, Mishra\u00a0GD, et\u00a0al. Promoting good mental health over the menopause transition. Lancet. 2024;403(10430):969\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(23)02801-5.","journal-title":"Lancet"},{"issue":"2","key":"2832_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","volume":"75","author":"JL Gordon","year":"2018","unstructured":"Gordon\u00a0JL, Rubinow\u00a0DR, Eisenlohr-Moul\u00a0TA, Xia\u00a0K, Schmidt\u00a0PJ, Girdler\u00a0SS. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial. JAMA Psychiatry. 2018;75(2):149\u201357. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3998.","journal-title":"JAMA Psychiatry"},{"key":"2832_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2026.121892","volume":"409","author":"Y Li","year":"2026","unstructured":"Li\u00a0Y, Sun\u00a0Y, Bi\u00a0Y, Yang\u00a0L, Xu\u00a0Y, Wu\u00a0H, et\u00a0al. Efficacy and safety of menopausal hormone therapy for depressive symptoms in perimenopausal women: A systematic review and meta-analysis. J\u00a0Affect Disord. 2026;409:121892. https:\/\/doi.org\/10.1016\/j.jad.2026.121892.","journal-title":"J Affect Disord"},{"key":"2832_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jad.2024.02.048","volume":"352","author":"A Spector","year":"2024","unstructured":"Spector\u00a0A, Li\u00a0Z, He\u00a0L, Badawy\u00a0Y, Desai\u00a0R. The effectiveness of psychosocial interventions on non-physiological symptoms of menopause: A\u00a0systematic review and meta-analysis. J\u00a0Affect Disord. 2024;352:460\u201372. https:\/\/doi.org\/10.1016\/j.jad.2024.02.048.","journal-title":"J Affect Disord"},{"issue":"24","key":"2832_CR32","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1001\/jama.2022.22744","volume":"328","author":"KL Szuhany","year":"2022","unstructured":"Szuhany\u00a0KL, Simon\u00a0NM. Anxiety Disorders: A\u00a0Review. JAMA. 2022;328(24):2431\u201345. https:\/\/doi.org\/10.1001\/jama.2022.22744.","journal-title":"JAMA"},{"key":"2832_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105851","volume":"143","author":"S Lozza-Fiacco","year":"2022","unstructured":"Lozza-Fiacco\u00a0S, Gordon\u00a0JL, Andersen\u00a0EH, Kozik\u00a0RG, Neely\u00a0O, Schiller\u00a0C, et\u00a0al. Baseline anxiety-sensitivity to estradiol fluctuations predicts anxiety symptom response to transdermal estradiol treatment in perimenopausal women - A randomized clinical trial. Psychoneuroendocrinology. 2022;143:105851. https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105851.","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"2832_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/GME.0000000000002190","volume":"30","author":"SJ Parish","year":"2023","unstructured":"Parish\u00a0SJ, Kling\u00a0JM. Testosterone use for hypoactive sexual desire disorder in postmenopausal women. Menopause. 2023;30(7):781\u20133. https:\/\/doi.org\/10.1097\/GME.0000000000002190.","journal-title":"Menopause"},{"key":"2832_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.maturitas.2019.07.001","volume":"128","author":"SR Davis","year":"2019","unstructured":"Davis\u00a0SR, Baber\u00a0R, Panay\u00a0N, Bitzer\u00a0J, Perez\u00a0SC, Islam\u00a0RM, et\u00a0al. Global Consensus Position Statement on the use of Testosterone Therapy for Women. Maturitas. 2019;128:89\u201393. https:\/\/doi.org\/10.1016\/j.maturitas.2019.07.001.","journal-title":"Maturitas"},{"issue":"10","key":"2832_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","volume":"7","author":"RM Islam","year":"2019","unstructured":"Islam\u00a0RM, Bell\u00a0RJ, Green\u00a0S, Page\u00a0MJ, Davis\u00a0SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754\u201366. https:\/\/doi.org\/10.1016\/S2213-8587(19)30189-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2832_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/a-1361-1948","volume":"81","author":"EC Inwald","year":"2021","unstructured":"Inwald\u00a0EC, Albring\u00a0C, Baum\u00a0E, Beckermann\u00a0M, B\u00fchling\u00a0KJ, Emons\u00a0G, et\u00a0al. Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG. Geburtshilfe Frauenheilkd. 2021;81(6):612\u201336. https:\/\/doi.org\/10.1055\/a-1361-1948.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2832_CR38","unstructured":"Center for Drug Evaluation and Research. Statistical Review and Evaluation. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2023\/216578Orig1s000StatR.pdf. Accessed: 19. Aug. 2026."},{"issue":"48","key":"2832_CR39","doi-asserted-by":"publisher","first-page":"19846","DOI":"10.1073\/pnas.1211517109","volume":"109","author":"MA Mittelman-Smith","year":"2012","unstructured":"Mittelman-Smith\u00a0MA, Williams\u00a0H, Krajewski-Hall\u00a0SJ, McMullen\u00a0NT, Rance\u00a0NE. Role for kisspeptin\/neurokinin B\/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. PNAS Nexus. 2012;109(48):19846\u201351. https:\/\/doi.org\/10.1073\/pnas.1211517109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2832_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng.306","volume":"41","author":"AK Topaloglu","year":"2009","unstructured":"Topaloglu\u00a0AK, Reimann\u00a0F, Guclu\u00a0M, Yalin\u00a0AS, Kotan\u00a0LD, Porter\u00a0KM, et\u00a0al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a\u00a0key role for Neurokinin B in the central control of reproduction. Nat Genet. 2009;41(3):354\u20138. https:\/\/doi.org\/10.1038\/ng.306.","journal-title":"Nat Genet"},{"issue":"3","key":"2832_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yfrne.2013.07.003","volume":"34","author":"NE Rance","year":"2013","unstructured":"Rance\u00a0NE, Dacks\u00a0PA, Mittelman-Smith\u00a0MA, Romanovsky\u00a0AA, Krajewski-Hall\u00a0SJ. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a\u00a0novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol. 2013;34(3):211\u201327. https:\/\/doi.org\/10.1016\/j.yfrne.2013.07.003.","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"2832_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.celrep.2018.06.037","volume":"24","author":"SL Padilla","year":"2018","unstructured":"Padilla\u00a0SL, Johnson\u00a0CW, Barker\u00a0FD, Patterson\u00a0MA, Palmiter\u00a0RD. A Neural Circuit Underlying the Generation of Hot Flushes. Cell Rep Med. 2018;24(2):271\u20137. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.037.","journal-title":"Cell Rep"},{"key":"2832_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep08466","volume":"5","author":"CN Jayasena","year":"2015","unstructured":"Jayasena\u00a0CN, Comninos\u00a0AN, Stefanopoulou\u00a0E, Buckley\u00a0A, Narayanaswamy\u00a0S, Izzi-Engbeaya\u00a0C, et\u00a0al. Neurokinin B administration induces hot flushes in women. Sci Rep. 2015;5:8466. https:\/\/doi.org\/10.1038\/srep08466.","journal-title":"Sci Rep"},{"issue":"7","key":"2832_CR44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka\u00a0T, Oliver-Williams\u00a0C, Kunutsor\u00a0S, Laven\u00a0JS, Fauser\u00a0BC, Chowdhury\u00a0R, et\u00a0al. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016;1(7):767\u201376. https:\/\/doi.org\/10.1001\/jamacardio.2016.2415.","journal-title":"JAMA Cardiol"},{"key":"2832_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.107974","volume":"185","author":"ER Uddenberg","year":"2024","unstructured":"Uddenberg\u00a0ER, Safwan\u00a0N, Saadedine\u00a0M, Hurtado\u00a0MD, Faubion\u00a0SS, Shufelt\u00a0CL. Menopause transition and cardiovascular disease risk. Maturitas. 2024;185:107974. https:\/\/doi.org\/10.1016\/j.maturitas.2024.107974.","journal-title":"Maturitas"},{"key":"2832_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.maturitas.2023.02.004","volume":"171","author":"A Armeni","year":"2023","unstructured":"Armeni\u00a0A, Anagnostis\u00a0P, Armeni\u00a0E, Mili\u00a0N, Goulis\u00a0D, Lambrinoudaki\u00a0I. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A\u00a0systematic review and meta-analysis. Maturitas. 2023;171:13\u201320. https:\/\/doi.org\/10.1016\/j.maturitas.2023.02.004.","journal-title":"Maturitas"},{"issue":"6","key":"2832_CR47","doi-asserted-by":"publisher","first-page":"898.e1","DOI":"10.1016\/j.ajog.2020.06.039","volume":"223","author":"D Zhu","year":"2020","unstructured":"Zhu\u00a0D, Chung\u00a0HF, Dobson\u00a0AJ, Pandeya\u00a0N, Anderson\u00a0DJ, Kuh\u00a0D, et\u00a0al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020;223(6):898.e1\u2013898.e16. https:\/\/doi.org\/10.1016\/j.ajog.2020.06.039.","journal-title":"Am J Obstet Gynecol"},{"key":"2832_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2018.08.009","volume":"117","author":"R Slopien","year":"2018","unstructured":"Slopien\u00a0R, Wender-Ozegowska\u00a0E, Rogowicz-Frontczak\u00a0A, Meczekalski\u00a0B, Zozulinska-Ziolkiewicz\u00a0D, Jaremek\u00a0JD, et\u00a0al. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018;117:6\u201310. https:\/\/doi.org\/10.1016\/j.maturitas.2018.08.009.","journal-title":"Maturitas"},{"issue":"4","key":"2832_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ejcn.2013.33","volume":"67","author":"K Duval","year":"2013","unstructured":"Duval\u00a0K, Prud\u2019homme\u00a0D, Rabasa-Lhoret\u00a0R, Strychar\u00a0I, Brochu\u00a0M, Lavoie\u00a0JM, et\u00a0al. Effects of the menopausal transition on energy expenditure: a\u00a0MONET Group Study. Eur J Clin Nutr. 2013;67(4):407\u201311. https:\/\/doi.org\/10.1038\/ejcn.2013.33.","journal-title":"Eur J Clin Nutr"},{"issue":"12","key":"2832_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124342","volume":"13","author":"KT Borer","year":"2021","unstructured":"Borer\u00a0KT, Lin\u00a0PJ, Wuorinen\u00a0E. Timing of Meals and Exercise Affects Hormonal Control of Glucoregulation, Insulin Resistance, Substrate Metabolism, and Gastrointestinal Hormones, but Has Little Effect on Appetite in Postmenopausal Women. Nutrients. 2021;13(12)4342. https:\/\/doi.org\/10.3390\/nu13124342.","journal-title":"Nutrients"},{"issue":"2","key":"2832_CR51","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/clinem\/dgae458","volume":"110","author":"N Hetem\u00e4ki","year":"2025","unstructured":"Hetem\u00e4ki\u00a0N, Robciuc\u00a0A, Vihma\u00a0V, Haanp\u00e4\u00e4\u00a0M, H\u00e4m\u00e4l\u00e4inen\u00a0E, Tikkanen\u00a0MJ, et\u00a0al. Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy. JCEM Case Rep. 2025;110(2):511\u201322. https:\/\/doi.org\/10.1210\/clinem\/dgae458.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2832_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/joim.12540","volume":"280","author":"U Smith","year":"2016","unstructured":"Smith\u00a0U, Kahn\u00a0BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J\u00a0Intern Med. 2016;280(5):465\u201375. https:\/\/doi.org\/10.1111\/joim.12540.","journal-title":"J Intern Med"},{"issue":"1","key":"2832_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EJE-18-0602","volume":"180","author":"P Anagnostis","year":"2019","unstructured":"Anagnostis\u00a0P, Christou\u00a0K, Artzouchaltzi\u00a0AM, Gkekas\u00a0NK, Kosmidou\u00a0N, Siolos\u00a0P, et\u00a0al. Early menopause and premature ovarian insufficiency are associated with increased risk of type\u00a02 diabetes: a\u00a0systematic review and meta-analysis. Eur J Endocrinol. 2019;180(1):41\u201350. https:\/\/doi.org\/10.1530\/EJE-18-0602.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2832_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12986-024-00858-0","volume":"21","author":"M Yazdkhasti","year":"2024","unstructured":"Yazdkhasti\u00a0M, Jafarabady\u00a0K, Shafiee\u00a0A, Omran\u00a0SP, Mahmoodi\u00a0Z, Esmaeilzadeh\u00a0S, et\u00a0al. The association between age of menopause and type\u00a02 diabetes: a\u00a0systematic review and meta-analysis. Nutr Metab (Lond). 2024;21(1):87\u201387. https:\/\/doi.org\/10.1186\/s12986-024-00858-0.","journal-title":"Nutr Metab (Lond)"},{"issue":"9","key":"2832_CR55","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.ajpath.2021.05.011","volume":"191","author":"M De Paoli","year":"2021","unstructured":"De Paoli\u00a0M, Zakharia\u00a0A, Werstuck\u00a0GH. The Role of Estrogen in Insulin Resistance: A Review of Clinical and Preclinical Data. Am J Pathol. 2021;191(9):1490\u20138. https:\/\/doi.org\/10.1016\/j.ajpath.2021.05.011.","journal-title":"Am J Pathol"},{"issue":"1","key":"2832_CR56","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf149.1939","volume":"9","author":"KC Haver","year":"2025","unstructured":"Haver\u00a0KC, Griffin\u00a0JN, Salas-Whalen\u00a0R, Haver\u00a0MC. MON-208 The Metabolic Syndrome of Menopause: The Role of Estrogen in an Interconnected Disease State. J\u00a0Endocr Soc. 2025;9(1)bvaf149.1939. https:\/\/doi.org\/10.1210\/jendso\/bvaf149.1939.","journal-title":"J Endocr Soc"},{"key":"2832_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1361","volume":"369","author":"E Vounzoulaki","year":"2020","unstructured":"Vounzoulaki\u00a0E, Khunti\u00a0K, Abner\u00a0SC, Tan\u00a0BK, Davies\u00a0MJ, Gillies\u00a0CL. Progression to type\u00a02 diabetes in women with a\u00a0known history of gestational diabetes: systematic review and meta-analysis. Can J Hosp Pharm. 2020;369:m1361. https:\/\/doi.org\/10.1136\/bmj.m1361.","journal-title":"BMJ"},{"key":"2832_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108625","volume":"171","author":"RA Dennison","year":"2021","unstructured":"Dennison\u00a0RA, Chen\u00a0ES, Green\u00a0ME, Legard\u00a0C, Kotecha\u00a0D, Farmer\u00a0G, et\u00a0al. The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies. Diabetes Res Clin Pract Suppl. 2021;171:108625. https:\/\/doi.org\/10.1016\/j.diabres.2020.108625.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"2832_CR59","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41574-022-00708-0","volume":"18","author":"I Lambrinoudaki","year":"2022","unstructured":"Lambrinoudaki\u00a0I, Paschou\u00a0SA, Armeni\u00a0E, Goulis\u00a0DG. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol. 2022;18(10):608\u201322. https:\/\/doi.org\/10.1038\/s41574-022-00708-0.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2832_CR60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/13697137.2023.2184252","volume":"26","author":"S Cerdas P\u00e9rez","year":"2023","unstructured":"Cerdas P\u00e9rez\u00a0S. Menopause and diabetes. Climacteric. 2023;26(3):216\u201321. https:\/\/doi.org\/10.1080\/13697137.2023.2184252.","journal-title":"Climacteric"},{"issue":"7","key":"2832_CR61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","volume":"29","author":"The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel","year":"2022","unstructured":"The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767\u201394. https:\/\/doi.org\/10.1097\/GME.0000000000002028.","journal-title":"Menopause"},{"issue":"3","key":"2832_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","volume":"67","author":"RE Nappi","year":"2010","unstructured":"Nappi\u00a0RE, Kokot-Kierepa\u00a0M. Women\u2019s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233\u20138. https:\/\/doi.org\/10.1016\/j.maturitas.2010.08.001.","journal-title":"Maturitas"},{"issue":"6","key":"2832_CR63","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/humupd\/dmab026","volume":"27","author":"AR Genazzani","year":"2021","unstructured":"Genazzani\u00a0AR, Monteleone\u00a0P, Giannini\u00a0A, Simoncini\u00a0T. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Hum Reprod Update. 2021;27(6):1115\u201350. https:\/\/doi.org\/10.1093\/humupd\/dmab026.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"2832_CR64","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/jwh.2014.5177","volume":"24","author":"M DiBonaventura","year":"2015","unstructured":"DiBonaventura\u00a0M, Luo\u00a0X, Moffatt\u00a0M, Bushmakin\u00a0AG, Kumar\u00a0M, Bobula\u00a0J. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe. Womens Health Rep. 2015;24(9):713\u201322. https:\/\/doi.org\/10.1089\/jwh.2014.5177.","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"2832_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065814","volume":"24","author":"LT Wang","year":"2023","unstructured":"Wang\u00a0LT, Chen\u00a0LR, Chen\u00a0KH. Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview. International Journal of Molecular Sciences. 2023;24(6)5814. https:\/\/doi.org\/10.3390\/ijms24065814.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2832_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00800-w","volume":"15","author":"P Hadji","year":"2020","unstructured":"Hadji\u00a0P, Hardtstock\u00a0F, Wilke\u00a0T, Joeres\u00a0L, Toth\u00a0E, M\u00f6ckel\u00a0L, et\u00a0al. Estimated epidemiology of osteoporosis diagnoses and osteoporosis-related high fracture risk in Germany: a\u00a0German claims data analysis. Arch Osteoporos. 2020;15(1)127. https:\/\/doi.org\/10.1007\/s11657-020-00800-w.","journal-title":"Arch Osteoporos"},{"issue":"1","key":"2832_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jbmr.534","volume":"27","author":"GA Greendale","year":"2012","unstructured":"Greendale\u00a0GA, Sowers\u00a0M, Han\u00a0W, Huang\u00a0MH, Finkelstein\u00a0JS, Crandall\u00a0CJ, et\u00a0al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women\u2019s Health Across the Nation (SWAN). J\u00a0Bone Miner Res. 2012;27(1):111\u20138. https:\/\/doi.org\/10.1002\/jbmr.534.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2832_CR68","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo\u00a0P, Kapoor\u00a0E, Asi\u00a0N, Alahdab\u00a0F, Mohammed\u00a0K, Benkhadra\u00a0K, et\u00a0al. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. J\u00a0Clin Endocrinol Metab. 2019;104(5):1623\u201330. https:\/\/doi.org\/10.1210\/jc.2019-00192. Erratum in: J Clin Endocrinol Metab. 2021;106(3):e1494.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6 Pt 1","key":"2832_CR69","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/01.gme.0000123641.76105.b5","volume":"11","author":"RD Wasnich","year":"2004","unstructured":"Wasnich\u00a0RD, Bagger\u00a0YZ, Hosking\u00a0DJ, McClung\u00a0MR, Wu\u00a0M, Mantz\u00a0AM, et\u00a0al. Changes in bone density and turnover after alendronate or estrogen withdrawal. Menopause. 2004;11(6 Pt 1):622\u201330. https:\/\/doi.org\/10.1097\/01.gme.0000123641.76105.b5.","journal-title":"Menopause"},{"issue":"7","key":"2832_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanhl.2025.100729","volume":"6","author":"Y Vinogradova","year":"2025","unstructured":"Vinogradova\u00a0Y, Iyen\u00a0B, Masud\u00a0T, Taylor\u00a0L, Kai\u00a0J. Discontinuation of menopausal hormone therapy and risk of fracture: nested case-control studies using routinely collected primary care data. Lancet Healthy Longev. 2025;6(7)100729. https:\/\/doi.org\/10.1016\/j.lanhl.2025.100729.","journal-title":"Lancet Healthy Longev"},{"key":"2832_CR71","unstructured":"Dachverband Osteologie. DVO Leitlinie Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei M\u00e4nnern ab dem 50.\u00a0Lebensjahr. 2023. https:\/\/leitlinien.dv-osteologie.org\/. Zugegriffen: 19. Aug. 2026."},{"key":"2832_CR72","unstructured":"FRAX. Calculation Tool. Available from: https:\/\/fraxplus.org\/calculation-tool. Accessed: 19. Aug. 2026."},{"issue":"13","key":"2832_CR73","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1503\/cmaj.071416","volume":"178","author":"C Berger","year":"2008","unstructured":"Berger\u00a0C, Langsetmo\u00a0L, Joseph\u00a0L, Hanley\u00a0DA, Davison\u00a0KS, Josse\u00a0R, et\u00a0al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ. 2008;178(13):1660\u20138. https:\/\/doi.org\/10.1503\/cmaj.071416.","journal-title":"CMAJ"},{"issue":"1","key":"2832_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101782","volume":"38","author":"TJ de Villiers","year":"2024","unstructured":"de Villiers\u00a0TJ. Bone health and menopause: Osteoporosis prevention and treatment. Best Pract Res Clin Endocrinol Metab. 2024;38(1)101782. https:\/\/doi.org\/10.1016\/j.beem.2023.101782.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2832_CR75","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/aogs.14523","volume":"102","author":"C McNestry","year":"2023","unstructured":"McNestry\u00a0C, Killeen\u00a0SL, Crowley\u00a0RK, McAuliffe\u00a0FM. Pregnancy complications and later life women\u2019s health. Acta Obstet Gynecol Scand. 2023;102(5):523\u201331. https:\/\/doi.org\/10.1111\/aogs.14523.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2832_CR76","doi-asserted-by":"publisher","first-page":"G49","DOI":"10.1093\/ejendo\/lvaf206","volume":"193","author":"MA Lumsden","year":"2025","unstructured":"Lumsden\u00a0MA, Dekkers\u00a0OM, Faubion\u00a0SS, Lind\u00e9n Hirschberg\u00a0A, Jayasena\u00a0CN, Lambrinoudaki\u00a0I, et\u00a0al. European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. Eur J Endocrinol. 2025;193(4):G49\u2013G81. https:\/\/doi.org\/10.1093\/ejendo\/lvaf206.","journal-title":"Eur J Endocrinol"},{"key":"2832_CR77","unstructured":"Leitlinie der \u00d6sterreichischen Gesellschaft f\u00fcr Knochen und Mineralstoffwechsel. Osteoporose \u2013 Definition, Risikoerfassung, Diagnose, Pr\u00e4vention und Therapie. Available from: https:\/\/www.oegkm.at\/interessierte\/leitlinien\/. Accessed: 19. Aug. 2026."},{"issue":"1","key":"2832_CR78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/cen.14789","volume":"100","author":"H Hamoda","year":"2024","unstructured":"Hamoda\u00a0H, Moger\u00a0S, Morris\u00a0E, Baldeweg\u00a0SE, Kasliwal\u00a0A, Gabbay\u00a0F. Menopause practice standards. Clin Endocrinol. 2024;100(1):50\u20135. https:\/\/doi.org\/10.1111\/cen.14789.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2832_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","volume":"329","author":"CJ Crandall","year":"2023","unstructured":"Crandall\u00a0CJ, Mehta\u00a0JM, Manson\u00a0JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405\u201320. https:\/\/doi.org\/10.1001\/jama.2022.24140.","journal-title":"JAMA"},{"key":"2832_CR80","doi-asserted-by":"publisher","unstructured":"Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6. Obstet Gynecol. 2023;142(5):1266\u201373. https:\/\/doi.org\/10.1097\/AOG.0000000000005395.","DOI":"10.1097\/AOG.0000000000005395"},{"key":"2832_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105994","volume":"149","author":"RC Arslan","year":"2023","unstructured":"Arslan\u00a0RC, Blake\u00a0K, Botzet\u00a0LJ, B\u00fcrkner\u00a0PC, DeBruine\u00a0L, Fiers\u00a0T, et\u00a0al. Not within spitting distance: Salivary immunoassays of estradiol have subpar validity for predicting cycle phase. Psychoneuroendocrinology. 2023;149:105994. https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105994.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"2832_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae065","volume":"2024","author":"N Panay","year":"2024","unstructured":"Panay\u00a0N, Anderson\u00a0RA, Bennie\u00a0A, Cedars\u00a0M, Davies\u00a0M, Ee\u00a0C, et\u00a0al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024(4)hoae065. https:\/\/doi.org\/10.1093\/hropen\/hoae065.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"2832_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.fertnstert.2024.11.007","volume":"123","author":"N Panay","year":"2025","unstructured":"Panay\u00a0N, Anderson\u00a0RA, Bennie\u00a0A, Cedars\u00a0M, Davies\u00a0M, Ee\u00a0C, et\u00a0al. Evidence-based guideline: Premature Ovarian Insufficiency. F S Rep. 2025;123(2):221\u201336. https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.007.","journal-title":"Fertil Steril"},{"issue":"6","key":"2832_CR84","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/GME.0000000000002200","volume":"30","author":"The North American Menopause Society","year":"2023","unstructured":"The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573\u201390. https:\/\/doi.org\/10.1097\/GME.0000000000002200.","journal-title":"Menopause"},{"key":"2832_CR85","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-030-64872-5_24","volume":"1308","author":"S Salari","year":"2021","unstructured":"Salari\u00a0S, Amiri\u00a0MS, Ramezani\u00a0M, Moghadam\u00a0AT, Elyasi\u00a0S, Sahebkar\u00a0A, et\u00a0al. Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review. Adv Exp Med Biol. 2021;1308:403\u201349. https:\/\/doi.org\/10.1007\/978-3-030-64872-5_24.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"2832_CR86","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/09513590.2022.2056591","volume":"38","author":"C Castelo-Branco","year":"2022","unstructured":"Castelo-Branco\u00a0C, Navarro\u00a0C, Beltr\u00e1n\u00a0E, Losa\u00a0F, Camacho\u00a0M. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement. Gynecol Endocrinol. 2022;38(5):379\u201384. https:\/\/doi.org\/10.1080\/09513590.2022.2056591.","journal-title":"Gynecol Endocrinol"},{"key":"2832_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000001089","author":"JC Weitlauf","year":"2026","unstructured":"Weitlauf\u00a0JC, Miles-McLean\u00a0HA, Millheiser\u00a0LS. Wait one hot minute: what exactly is cognitive behavioral therapy for menopause? Curr Opin Obstet Gynecol. 2026; https:\/\/doi.org\/10.1097\/GCO.0000000000001089. Online im Druck..","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"2832_CR88","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13697137.2020.1777965","volume":"24","author":"MS Hunter","year":"2021","unstructured":"Hunter\u00a0MS. Cognitive behavioral therapy for menopausal symptoms. Climacteric. 2021;24(1):51\u20136. https:\/\/doi.org\/10.1080\/13697137.2020.1777965.","journal-title":"Climacteric"},{"issue":"3","key":"2832_CR89","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(11)70364-3","volume":"13","author":"E Mann","year":"2012","unstructured":"Mann\u00a0E, Smith\u00a0MJ, Hellier\u00a0J, Balabanovic\u00a0JA, Hamed\u00a0H, Grunfeld\u00a0EA, et\u00a0al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13(3):309\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(11)70364-3.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2832_CR90","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","volume":"20","author":"GR Elkins","year":"2013","unstructured":"Elkins\u00a0GR, Fisher\u00a0WI, Johnson\u00a0AK, Carpenter\u00a0JS, Keith\u00a0TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a\u00a0randomized controlled trial. Menopause. 2013;20(3):291\u20138. https:\/\/doi.org\/10.1097\/gme.0b013e31826ce3ed.","journal-title":"Menopause"},{"issue":"11","key":"2832_CR91","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.42537","volume":"8","author":"G Elkins","year":"2025","unstructured":"Elkins\u00a0G, Arring\u00a0N, Morgan\u00a0G, Lorenz\u00a0T, Muniz\u00a0V, Lafferty\u00a0C, et\u00a0al. Self-Administered Hypnosis vs Sham Hypnosis for Hot Flashes: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(11)e2542537. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.42537.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2832_CR92","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/2156587217708523","volume":"22","author":"JR Sliwinski","year":"2017","unstructured":"Sliwinski\u00a0JR, Elkins\u00a0GR. Hypnotherapy to Reduce Hot Flashes: Examination of Response Expectancies as a\u00a0Mediator of Outcomes. J\u00a0Evid Based Complementary Altern Med. 2017;22(4):652\u20139. https:\/\/doi.org\/10.1177\/2156587217708523.","journal-title":"J Evid Based Complementary Altern Med"},{"key":"2832_CR93","unstructured":"Bundesamt f\u00fcr Sicherheit im Gesundheitswesen (BASG). Fachinformation. Available from: www.basg.gv.at. Accessed: 19. Aug. 2026."},{"key":"2832_CR94","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). Fachinformation. Available from: www.portal.dimdi.de. Accessed: 19. Aug. 2026."},{"key":"2832_CR95","unstructured":"Suchplattform Fach- und Patienteninformationen der zugelassenen Humanarzneimittel (AIPS). Fachinformation. Available from: www.swissmedicinfo.ch. Accessed: 19. Aug. 2026."},{"issue":"10382","key":"2832_CR96","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0140-6736(23)00085-5","volume":"401","author":"S Lederman","year":"2023","unstructured":"Lederman\u00a0S, Ottery\u00a0FD, Cano\u00a0A, Santoro\u00a0N, Shapiro\u00a0M, Stute\u00a0P, et\u00a0al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023;401(10382):1091\u2013102. https:\/\/doi.org\/10.1016\/S0140-6736(23)00085-5.","journal-title":"Lancet"},{"issue":"8","key":"2832_CR97","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1210\/clinem\/dgad058","volume":"108","author":"KA Johnson","year":"2023","unstructured":"Johnson\u00a0KA, Martin\u00a0N, Nappi\u00a0RE, Neal-Perry\u00a0G, Shapiro\u00a0M, Stute\u00a0P, et\u00a0al. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A\u00a0Phase\u00a03\u00a0RCT. JCEM Case Rep. 2023;108(8):1981\u201397. https:\/\/doi.org\/10.1210\/clinem\/dgad058.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2832_CR98","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/AOG.0000000000005114","volume":"141","author":"G Neal-Perry","year":"2023","unstructured":"Neal-Perry\u00a0G, Cano\u00a0A, Lederman\u00a0S, Nappi\u00a0RE, Santoro\u00a0N, Wolfman\u00a0W, et\u00a0al. Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstet Gynecol. 2023;141(4):737\u201347. https:\/\/doi.org\/10.1097\/AOG.0000000000005114.","journal-title":"Obstet Gynecol"},{"key":"2832_CR99","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). Rote-Hand-Brief zu Veoza (Fezolinetant): Risiko f\u00fcr arzneimittelbedingten Leberschaden und neue Empfehlungen zur \u00dcberpr\u00fcfung der Leberfunktion vor und w\u00e4hrend der Behandlung. Available from: https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2025\/rhb-fezolinetant.html. Accessed: 19. Aug. 2026."},{"issue":"3","key":"2832_CR100","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/GME.0000000000002138","volume":"30","author":"JA Simon","year":"2023","unstructured":"Simon\u00a0JA, Anderson\u00a0RA, Ballantyne\u00a0E, Bolognese\u00a0J, Caetano\u00a0C, Joffe\u00a0H, et\u00a0al. Efficacy and safety of elinzanetant, a selective neurokinin\u20111,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1). Menopause. 2023;30(3):239\u201346. https:\/\/doi.org\/10.1097\/GME.0000000000002138.","journal-title":"Menopause"},{"issue":"16","key":"2832_CR101","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jama.2024.14618","volume":"332","author":"JV Pinkerton","year":"2024","unstructured":"Pinkerton\u00a0JV, Simon\u00a0JA, Joffe\u00a0H, Maki\u00a0PM, Nappi\u00a0RE, Panay\u00a0N, et\u00a0al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA. 2024;332(16):1343\u201354. https:\/\/doi.org\/10.1001\/jama.2024.14618.","journal-title":"JAMA"},{"key":"2832_CR102","doi-asserted-by":"publisher","unstructured":"Rada\u00a0G, Capurro\u00a0D, Pantoja\u00a0T, Corbal\u00e1n\u00a0J, Moreno\u00a0G, Letelier\u00a0LM, et\u00a0al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;CD004923. https:\/\/doi.org\/10.1002\/14651858.CD004923.pub2.","DOI":"10.1002\/14651858.CD004923.pub2"},{"key":"2832_CR103","unstructured":"SmPC. Brisdelle. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/204516s009s014lbl.pdf. Accessed: 19. Aug. 2026."},{"issue":"3","key":"2832_CR104","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1210\/en.2018-00529","volume":"160","author":"RJ Santen","year":"2019","unstructured":"Santen\u00a0RJ, Simpson\u00a0E. History of Estrogen: Its Purification, Structure, Synthesis, Biologic Actions, and Clinical Implications. Endocrinology. 2019;160(3):605\u201325. https:\/\/doi.org\/10.1210\/en.2018-00529.","journal-title":"Endocrinology"},{"key":"2832_CR105","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1152\/ajplegacy.1929.88.2.326","volume":"88","author":"GW Corner","year":"1929","unstructured":"Corner\u00a0GW, Allen\u00a0WM. Physiology of the corpus luteum, II: production of a\u00a0special uterine reaction (progestational proliferation) by extracts of the corpus luteum. American Journal of Physiology-Legacy Content. 1929;88:326\u201339. https:\/\/doi.org\/10.1152\/ajplegacy.1929.88.2.326.","journal-title":"American Journal of Physiology-Legacy Content"},{"issue":"4","key":"2832_CR106","first-page":"282","volume":"11","author":"DA Vance","year":"2007","unstructured":"Vance\u00a0DA Dph. Premarin: the intriguing history of a controversial drug. Int J Pharm Compd. 2007;11(4):282\u20136.","journal-title":"Int J Pharm Compd"},{"issue":"1","key":"2832_CR107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/AOG.0000000000005553","volume":"144","author":"B Levy","year":"2024","unstructured":"Levy\u00a0B, Simon\u00a0JA. A\u00a0Contemporary View of Menopausal Hormone Therapy. Obstet Gynecol. 2024;144(1):12\u201323. https:\/\/doi.org\/10.1097\/AOG.0000000000005553.","journal-title":"Obstet Gynecol"},{"issue":"13","key":"2832_CR108","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","volume":"374","author":"HN Hodis","year":"2016","unstructured":"Hodis\u00a0HN, Mack\u00a0WJ, Henderson\u00a0VW, Shoupe\u00a0D, Budoff\u00a0MJ, Hwang-Levine\u00a0J, et\u00a0al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med. 2016;374(13):1221\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1505241.","journal-title":"N Engl J Med"},{"issue":"1","key":"2832_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35826-w","volume":"13","author":"JC Prior","year":"2023","unstructured":"Prior\u00a0JC, Cameron\u00a0A, Fung\u00a0M, Hitchcock\u00a0CL, Janssen\u00a0P, Lee\u00a0T, et\u00a0al. Oral micronized progesterone for perimenopausal night sweats and hot flushes a\u00a0Phase\u00a0III Canada-wide randomized placebo-controlled 4\u00a0month trial. Sci Rep. 2023;13(1)9082. https:\/\/doi.org\/10.1038\/s41598-023-35826-w. Erratum in: Sci Rep. 2024;14(1):17229.","journal-title":"Sci Rep"},{"issue":"5","key":"2832_CR110","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1056\/NEJMcp1714787","volume":"382","author":"JV Pinkerton","year":"2020","unstructured":"Pinkerton\u00a0JV. Hormone Therapy for Postmenopausal Women. N Engl J Med. 2020;382(5):446\u201355. https:\/\/doi.org\/10.1056\/NEJMcp1714787.","journal-title":"N Engl J Med"},{"issue":"6","key":"2832_CR111","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","volume":"307","author":"M\u0160 Gold\u0161tajn","year":"2023","unstructured":"Gold\u0161tajn\u00a0M\u0160, Miku\u0161\u00a0M, Ferrari\u00a0FA, Bosco\u00a0M, Uccella\u00a0S, Noventa\u00a0M, et\u00a0al. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a\u00a0systematic review. Arch Gynecol Obstet. 2023;307(6):1727\u201345. https:\/\/doi.org\/10.1007\/s00404-022-06647-5.","journal-title":"Arch Gynecol Obstet"},{"issue":"15","key":"2832_CR112","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jama.2026.1891","volume":"335","author":"D Bartz","year":"2026","unstructured":"Bartz\u00a0D, Tadikonda\u00a0A, Manson\u00a0JE. Opportunity for Improved Menopausal Hormone Therapy Prescribing. JAMA. 2026;335(15):1297\u20139. https:\/\/doi.org\/10.1001\/jama.2026.1891.","journal-title":"JAMA"},{"issue":"5","key":"2832_CR113","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/13697137.2025.2503874","volume":"28","author":"A Hicks","year":"2025","unstructured":"Hicks\u00a0A, Robson\u00a0D, Tellis\u00a0B, Smith\u00a0S, Dunkley\u00a0S, Baber\u00a0R. Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a\u00a0systematic review. Climacteric. 2025;28(5):497\u2013509. https:\/\/doi.org\/10.1080\/13697137.2025.2503874.","journal-title":"Climacteric"},{"issue":"2","key":"2832_CR114","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMcp2116488","volume":"388","author":"CA Stuenkel","year":"2023","unstructured":"Stuenkel\u00a0CA, Gompel\u00a0A. Primary Ovarian Insufficiency. N Engl J Med. 2023;388(2):154\u201363. https:\/\/doi.org\/10.1056\/NEJMcp2116488.","journal-title":"N Engl J Med"},{"issue":"2","key":"2832_CR115","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/GME.0000000000002459","volume":"32","author":"S Glynne","year":"2025","unstructured":"Glynne\u00a0S, Reisel\u00a0D, Kamal\u00a0A, Neville\u00a0A, McColl\u00a0L, Lewis\u00a0R, et\u00a0al. The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study. Menopause. 2025;32(2):103\u201311. https:\/\/doi.org\/10.1097\/GME.0000000000002459.","journal-title":"Menopause"},{"issue":"Suppl 1","key":"2832_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13697130500148875","volume":"8","author":"H Kuhl","year":"2005","unstructured":"Kuhl\u00a0H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3\u201363. https:\/\/doi.org\/10.1080\/13697130500148875.","journal-title":"Climacteric"},{"issue":"6","key":"2832_CR117","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/GME.0000000000002723","volume":"33","author":"SJ Glynne","year":"2026","unstructured":"Glynne\u00a0SJ, Simon\u00a0JA. Tailoring transdermal estradiol dose to maximize benefits and minimize risks. Menopause. 2026;33(6):743\u201353. https:\/\/doi.org\/10.1097\/GME.0000000000002723.","journal-title":"Menopause"},{"key":"2832_CR118","unstructured":"British Menopause Society. Tool for Clinicians. Measurement of serum estradiol in the menopause transition. 2025. https:\/\/thebms.org.uk\/wp-content\/uploads\/2025\/11\/24-NEW-BMS-ToolsforClinicians-Measurement-of-serum-estradiol-JULY2025-C.pdf. Zugegriffen: 19. Aug. 2026."},{"issue":"5","key":"2832_CR119","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jsxm.2020.10.009","volume":"18","author":"SJ Parish","year":"2021","unstructured":"Parish\u00a0SJ, Simon\u00a0JA, Davis\u00a0SR, Giraldi\u00a0A, Goldstein\u00a0I, Goldstein\u00a0SW, et\u00a0al. International Society for the Study of Women\u2019s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J\u00a0Sex Med. 2021;18(5):849\u201367. https:\/\/doi.org\/10.1016\/j.jsxm.2020.10.009.","journal-title":"J Sex Med"},{"issue":"1","key":"2832_CR120","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000003324","volume":"134","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology","year":"2019","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology. Female Sexual Dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol. 2019;134(1):e1\u2013e18. https:\/\/doi.org\/10.1097\/AOG.0000000000003324.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2832_CR121","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13697137.2019.1637079","volume":"22","author":"SR Davis","year":"2019","unstructured":"Davis\u00a0SR, Baber\u00a0R, Panay\u00a0N, Bitzer\u00a0J, Cerdas Perez\u00a0S, Islam\u00a0RM, et\u00a0al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Climacteric. 2019;22(5):429\u201334. https:\/\/doi.org\/10.1080\/13697137.2019.1637079.","journal-title":"Climacteric"},{"issue":"9","key":"2832_CR122","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMp1514242","volume":"374","author":"JE Manson","year":"2016","unstructured":"Manson\u00a0JE, Kaunitz\u00a0AM. Menopause Management--Getting Clinical Care Back on Track. N Engl J Med. 2016;374(9):803\u20136. https:\/\/doi.org\/10.1056\/NEJMp1514242.","journal-title":"N Engl J Med"},{"issue":"12","key":"2832_CR123","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/ijc.31267","volume":"142","author":"ECL L\u00f8kkegaard","year":"2018","unstructured":"L\u00f8kkegaard\u00a0ECL, M\u00f8rch\u00a0LS. Tibolone and risk of gynecological hormone sensitive cancer. Int J Cancer. 2018;142(12):2435\u201340. https:\/\/doi.org\/10.1002\/ijc.31267.","journal-title":"Int J Cancer"},{"issue":"6","key":"2832_CR124","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/GME.0000000000002185","volume":"30","author":"N Meziou","year":"2023","unstructured":"Meziou\u00a0N, Scholfield\u00a0C, Taylor\u00a0CA, Armstrong\u00a0HL. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a\u00a0systematic review and meta-analysis update. Menopause. 2023;30(6):659\u201371. https:\/\/doi.org\/10.1097\/GME.0000000000002185.","journal-title":"Menopause"},{"key":"2832_CR125","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078784","volume":"387","author":"T Johansson","year":"2024","unstructured":"Johansson\u00a0T, Karlsson\u00a0T, Bliuc\u00a0D, Schmitz\u00a0D, Ek\u00a0WE, Skalkidou\u00a0A, et\u00a0al. Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial. Can J Hosp Pharm. 2024;387:e078784. https:\/\/doi.org\/10.1136\/bmj-2023-078784.","journal-title":"BMJ"},{"key":"2832_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.maturitas.2018.07.016","volume":"116","author":"U Sauer","year":"2018","unstructured":"Sauer\u00a0U, Talaulikar\u00a0V, Davies\u00a0MC. Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase. Maturitas. 2018;116:79\u201382. https:\/\/doi.org\/10.1016\/j.maturitas.2018.07.016.","journal-title":"Maturitas"},{"issue":"6","key":"2832_CR127","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/13697137.2025.2585487","volume":"28","author":"N Panay","year":"2025","unstructured":"Panay\u00a0N, Fenton\u00a0A, Hamoda\u00a0H, Hillard\u00a0T, Islam\u00a0R, Pedder\u00a0H, et\u00a0al. International Menopause Society (IMS) recommendations and key messages on women\u2019s midlife health and menopause. Climacteric. 2025;28(6):634\u201356. https:\/\/doi.org\/10.1080\/13697137.2025.2585487.","journal-title":"Climacteric"},{"issue":"6","key":"2832_CR128","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/GME.0000000000002187","volume":"30","author":"MM Christmas","year":"2023","unstructured":"Christmas\u00a0MM, Iyer\u00a0S, Daisy\u00a0C, Maristany\u00a0S, Letko\u00a0J, Hickey\u00a0M. Menopause hormone therapy and urinary symptoms: a systematic review. Menopause. 2023;30(6):672\u201385. https:\/\/doi.org\/10.1097\/GME.0000000000002187.","journal-title":"Menopause"},{"key":"2832_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101574","volume":"62","author":"R Cardoso","year":"2025","unstructured":"Cardoso\u00a0R, Ola\u00a0I, Jansen\u00a0L, Hackl\u00a0M, Ihle\u00a0P, Francart\u00a0J, et\u00a0al. Breast cancer incidence, by stage at diagnosis, and mortality in 21\u00a0European countries in the era of mammography screening: an international population-based study. Lancet Reg Health Eur. 2025;62:101574. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101574.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"2832_CR130","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw\u00a0JE, Anderson\u00a0GL, Prentice\u00a0RL, LaCroix\u00a0AZ, Kooperberg\u00a0C, Stefanick\u00a0ML, et\u00a0al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333. https:\/\/doi.org\/10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"issue":"14","key":"2832_CR131","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson\u00a0GL, Limacher\u00a0M, Assaf\u00a0AR, Bassford\u00a0T, Beresford\u00a0SA, Black\u00a0H, et\u00a0al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701\u201312. https:\/\/doi.org\/10.1001\/jama.291.14.1701.","journal-title":"JAMA"},{"issue":"24","key":"2832_CR132","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski\u00a0RT, Hendrix\u00a0SL, Langer\u00a0RD, Stefanick\u00a0ML, Gass\u00a0M, Lane\u00a0D, et\u00a0al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial. JAMA. 2003;289(24):3243\u201353. https:\/\/doi.org\/10.1001\/jama.289.24.3243.","journal-title":"JAMA"},{"issue":"3","key":"2832_CR133","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-8587(25)00394-8","volume":"14","author":"A Gompel","year":"2026","unstructured":"Gompel\u00a0A, Simcock\u00a0R. Menopausal hormone treatment and breast cancer. Lancet Diabetes Endocrinol. 2026;14(3):259\u201374. https:\/\/doi.org\/10.1016\/S2213-8587(25)00394-8. Erratum in: Lancet Diabetes Endocrinol. 2026;14(8):e11.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2832_CR134","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","volume":"85","author":"D Grady","year":"1995","unstructured":"Grady\u00a0D, Gebretsadik\u00a0T, Kerlikowske\u00a0K, Ernster\u00a0V, Petitti\u00a0D. Hormone replacement therapy and endometrial cancer risk: a\u00a0meta-analysis. Obstet Gynecol. 1995;85(2):304\u201313. https:\/\/doi.org\/10.1016\/0029-7844(94)00383-O.","journal-title":"Obstet Gynecol"},{"issue":"9470","key":"2832_CR135","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","volume":"365","author":"V Beral","year":"2005","unstructured":"Beral\u00a0V, Bull\u00a0D, Reeves\u00a0G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365(9470):1543\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(05)66455-0.","journal-title":"Lancet"},{"issue":"5","key":"2832_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051443","volume":"13","author":"P Villa","year":"2024","unstructured":"Villa\u00a0P, Bounous\u00a0VE, Amar\u00a0ID, Bernardini\u00a0F, Giorgi\u00a0M, Attianese\u00a0D, et\u00a0al. Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review. J\u00a0Clin Med. 2024;13(5)1443. https:\/\/doi.org\/10.3390\/jcm13051443.","journal-title":"J Clin Med"},{"issue":"6","key":"2832_CR137","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-012-9694-6","volume":"27","author":"S Morois","year":"2012","unstructured":"Morois\u00a0S, Fournier\u00a0A, Clavel-Chapelon\u00a0F, Mesrine\u00a0S, Boutron-Ruault\u00a0MC. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias? Eur J Epidemiol. 2012;27(6):439\u201352. https:\/\/doi.org\/10.1007\/s10654-012-9694-6.","journal-title":"Eur J Epidemiol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-026-02832-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-026-02832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:03:17Z","timestamp":1791856997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-026-02832-7"}},"subtitle":["Konsensuspapier der \u00d6sterreichischen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (OEGGG), der Deutschen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (DGGG), der Deutschen Menopause Gesellschaft (DMG) und der Schweizerischen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (SGGG)","Consensus paper of the Austrian Society for Gynecology and Obstetrics (OEGGG), the German Society for Gynecology and Obstetrics (DGGG), the German Menopause Society (DMG) and the Swiss Society for Gynecology and Obstetrics (SGGG)"],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":137,"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1007\/s00508-026-02832-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"8 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.\u00a0Toth: Vortragshonorare: Astellas GmbH, Novartis GmbH, Theramex GmbH, \u00d6sterreichische \u00c4rzteakademie, OEGGG Akademie, Reisekostenunterst\u00fctzung: IBSA, advisory board: Ferring. D.\u00a0Gruber: Vortragshonorare von Institut AllergoSan, Kwizda Pharma GmbH; Astellas GmbH. G.\u00a0Naumann: Beratung und Teilnahme an klinischen Studien f\u00fcr Promedon, advisory board: Dr. Pfleger GmbH. S.\u00a0Weidlinger: Vortr\u00e4ge, Advisory Boards, Kongresskostenunterst\u00fctzung: Bayer, Besins Healthcare, EFFIK, IBSA und Labatec. J.\u00a0Ott: Vortragshonorare von Astellas GmbH, Eli Lilly GmbH, Exeltis GmbH, Gedeon Richter GmbH; Lenus Pharma GmbH; Advisory boards: Astellas GmbH, Exeltis GmbH, Gedeon Richter GmbH. K.\u00a0Schaudig: Vortragshonorare bzw. advisory boards: Alpinion medical Deutschland GmbH, Astellas Pharma GmbH, Bayer Jenapharm GmbH, B\u00e9sins-Health-Care Germany GmbH, Exeltis GmbH, Fidia Farmaceutici S.P.A., Gedeon Richter Pharma GmbH, Lilly Pharma GmbH, Novartis GmbH, Novo Nordisk Pharma GmbH, Organon Health Care GmbH, Side Kick Health Germany GmbH (vormals Sidekick Health), Th\u00e9a Pharma GmbH, Theramex GmbH, Viatris, Laborarztpraxis Rhein-Main, Berufsverband der Frauen\u00e4rzte, Deutsche Menopause Gesellschaft.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}